Counselors in Marysville, MI Accepting Medicare

6 Counselors found. Showing 1 - 6

Ghada Rose Alizz Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 195 Huron Blvd, Marysville, MI 48040 Phone: 989-401-2244

Stacy Maclean Healy, MA LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1600 Gratiot Blvd Ste 4 Bldg B, Marysville, MI 48040 Phone: 810-364-5800    Fax: 810-364-1200

Karshibia Davidson, MS, LPC, NCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 1020 Hunter Ct, Marysville, MI 48040 Phone: 887-887-1458    Fax: 888-788-7145

Tammy Sue Wilson, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 626 Busha Hwy, Marysville, MI 48040 Phone: 810-637-1183    Fax: 810-637-1183

Mrs. Betty Jean Arnold, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1600 Gratiot Blvd, Bldg B, Suite 4, Marysville, MI 48040 Phone: 810-364-5800    Fax: 810-364-1200

John Harry Heidtke, M.A., LMSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1600 Gratiot Blvd, Bldg. B, Suite 4, Marysville, MI 48040 Phone: 810-364-5800    Fax: 810-364-1200

News Archive

New approach shows promise for treating shoulder pain in wheelchair users with spinal cord injury

Researchers in regenerative rehabilitation conducted a pilot study of a new approach to the treatment of treatment-resistant shoulder pain in wheelchair users with spinal cord injury (SCI) and rotator cuff disease.

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech's milk-derived exosome platform technology for the oral administration of Roche's antisense oligonucleotide platform.

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

Galapagos NV announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to incorporate the development of new therapies for atherosclerosis.

Epigenetic changes to DNA in breast cancers linked with environmental risk factors, tumor size: Study

Researchers from Brown University and the University of California San Francisco have found that epigenetic changes to DNA in breast cancers are related to environmental risk factors and tumor size, providing a window into the severity of the disease. The study is published in today's edition of PLoS Genetics. The researchers found that epigenetic profiles of tumors had a direct association with diet, alcohol, and tumor size.

Read more Medical News

› Verified 5 days ago